Daniel Faga, Chief Business Officer at Spark Therapeutics, Inc. (ONCE), sold 4,500 shares at $62.71 ($282K) on 2017-06-29, disclosed to the SEC on 2017-06-29.
Open-market sale of $282k ONCE by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ANAB | SELL | 2026-01-08 | $415K | — | Filing → |
| ANAB | SELL | 2026-01-06 | $662K | — | Filing → |
| ANAB | SELL | 2024-03-26 | $6.8M | — | Filing → |